Afatinib Dimaleate Tablet 40mg Xovoltib

What is the purpose of the medicine Afatinib Dimaleate Tablet?

Afatinib Dimaleate Tablet is a drug that is used to treat non-small cell lung cancer (NSCLC) that has progressed to neighboring tissues or other sections of the body. Afatinib belongs to the kinase inhibitor class of drugs.

Is afatinib associated with weight gain?

If you experience any very serious side effects, seek medical attention right away. These include signs of lung difficulties (such as difficulty breathing, chest discomfort), symptoms of heart failure (such as shortness of breath, swelling ankles/feet, unusual weariness, and unusual/sudden weight gain).

What are the Afatinib Dimaleate Tablet side effects?

• Consequences
• Urine that is bloody or cloudy.
• Eyes that are burning, dry, or itchy.
• Urination that is difficult, scorching, or painful.
• severe ripping or discharge
• Urge to urinate on a regular basis.
• The eye, eyelid, or inner lining of the eyelid may be red, painful, or swollen.
• The skin is fragile to may be red, swollen, or painful.
• The flesh on the hands and feet begins to scald.

Is it safe to drink alcohol when taking afatinib?

Alcohol consumption (in tiny doses) appears to have no effect on the safety or effectiveness of afatinib. with afatinib treatment and for 2 weeks following the last dose If you or your partner becomes pregnant, call your doctor straight away.

Is afatinib hazardous to the body?

Afatinib Dimaleate Tablet is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor of the second generation (TKI). Afatinib has been demonstrated to be more effective than cytotoxic chemotherapy in the treatment of non-small cell lung cancer with EGFR mutations.

How long does erlotinib take to take effect?

In the fraction of individuals with EGFR mutations, erlotinib is quite successful. However, after around 12 months of erlotinib therapy, even these patients will begin to show signs of cancer progression.

Erlotinib belongs to what drug class?

Erlotinib belongs to the class of medicines known as kinase inhibitors. It works by preventing cancer cells from multiplying by stopping the action of an aberrant protein this delays or stops the spread of cancer cells.

Is afatinib able to pass through the blood-brain barrier?

According to new research, the second-and third-generation EGFR TKIs, afatinib, and osimertinib, successfully permeate the blood-brain barrier, making them feasible therapy alternatives for CNS lesions and potentially lowering the risk of CNS progression.

if you are looking for another brand or product click on emfib